Changes in Recombinant Human Growth Hormone Prescribing Information (PES D & T Committee 2008)

Members of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society describe the changes in the prescribing information for the different forms of
rhGH.

Read More

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents (Circul 2007)

A Scientific Statement from the American Heart Association on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents.

Read More

Consensus Statement on Management of Intersex Disorders

The birth of an intersex child prompts a long-term management strategy that involves myriad professionals working with the family. There has been progress in diagnosis, surgical…

Read More

Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes. PES D&T Committee Position statement. (Pediatrics 2006)

This review summarizes efficacy and safety of continuous subcutaneous insulin infusion in children ≤6 years of age, present potential pros and cons of using insulin pumps…

Read More

Childhood Obesity (JCEM 2005)

A consensus statement on the widespread public health crisis in childhood obesity.

Read More

ESPE/PES Consensus Statement on DKA in Children and Adolescents (Pediatrics 2004)

There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral edema and the appropriate site(s) for children with DKA…

Read More